HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Zacks Rank    Equity Research    Obama Stocks    My Account    Help    
FREE winning picks
Quote:
Login
Search:

Commentary BETA - Give us your feedback
Analyst Blog

Sonic Innovations a Sound Buy

By: Tom Park
November 03, 2008 | Comments: 0
Recommended this article (0)
Print    Share

Sonic Innovations, Inc. (SNCI - Analyst Report) designs, develops, manufactures and markets advanced digital hearing aids, designed to provide the highest levels of satisfaction for hearing-impaired consumers. Capitalizing on its advanced understanding of human hearing, the company has developed patented digital signal processing (DSP) technologies, and embedded them into the smallest single-chip DSP platform ever installed in a hearing aid.

SNCI reported Q3 EPS that beat our estimate by $0.08 on sales that exceeded our forecast. We increased our FY08 sales and EPS estimates. We lowered our FY09 sales estimate but increased our FY09 EPS estimate. The company finally gave up on Tympany and the referral concept and instead has expanded its distribution relationships and is acquiring practices and opening new clinics to help drive meaningful sales growth from new product launches.

Sonic Innovations has been consolidating operations in Europe to reduce operating costs and to focus resources on markets that offer the greatest profitability. Our price target is based on a price-to-sales multiple of roughly 0.6x FY09 sales estimate.

Read the full analyst report on SNCI


Email

Print

Share

RSS

Rate Pos

Rate Neg

Comment
Read/Post Comments (0) | Recommended this article (0)
 Posting Comment...
There was a problem posting this this comment. Please try back later.
[CLICK TO CLOSE X]
Comments (Limit 1000 Characters - Used: 0)
Display Name: Email Address:  
 Loading Comments...
Be the first to comment on this article!

More Zacks Resources

Market Summary Jul 04, 2009 18:51 pm ET
DJIA 8280.74  -223.32 -2.63%
NASD 1796.52  -49.20 -2.67%
S&P 500 896.42  -26.91 -2.91%
Sponsored Links
Commentary Beta
GIVE US YOUR FEEDBACK